• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性和良性甲状腺肿瘤细胞中谷胱甘肽S-转移酶(GST)系统患病率的比较分析。

Comparative analysis of the prevalence of the glutathione S-transferase (GST) system in malignant and benign thyroid tumor cells.

作者信息

Gonçalves Antonio José, Carvalho Lucia Helena de, Serdeira Kauê, Nakai Marianne Yumi, Malavasi Tatiana Ramos

机构信息

Faculdade de Ciências Médicas da Santa Casa de Misericórdia de São Paulo, São Paulo, Brazil.

出版信息

Sao Paulo Med J. 2007 Sep 6;125(5):289-91. doi: 10.1590/s1516-31802007000500008.

DOI:10.1590/s1516-31802007000500008
PMID:18094897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11041513/
Abstract

CONTEXT AND OBJECTIVE

When null, the mu and theta genes of the glutathione S-transferase system (GSTM1 and GSTT1, respectively) are related to malignant tumors affecting the lungs, colon, prostate, bladder and head and neck. In the thyroid, the appearance of cancer has been correlated with deletion of these genes. The aim of this study was to compare the frequencies of these genes in patients with benign and malignant tumors of the thyroid gland.

DESIGN AND SETTINGS

This was a cross-sectional clinical trial carried out in the Head and Neck Surgery Division, Faculdade de Medicina da Santa Casa de São Paulo.

METHODS

Samples of thyroid tissue were collected from 32 patients and divided into two groups: benign tumor (A) and malignant tumor (B). After DNA extraction, the genes were amplified using PCR.

RESULTS

The B group presented four cases of positive genotyping for both genes, seven positive for GSTT1 and negative for GSTM1, two negative for GSTT1 and positive for GSTM1, and only one case of double negative. The A group showed 11 cases with positive genotyping for both genes and none with the double negative genotype.

CONCLUSION

In this study, there was no relationship between the presence of the GSTT1 and GSTM1 genes and the benign and malignant thyroid tumors.

摘要

背景与目的

谷胱甘肽S-转移酶系统的μ和θ基因(分别为GSTM1和GSTT1)缺失时,与影响肺、结肠、前列腺、膀胱及头颈部的恶性肿瘤相关。在甲状腺中,癌症的出现与这些基因的缺失有关。本研究的目的是比较甲状腺良性和恶性肿瘤患者中这些基因的频率。

设计与背景

这是一项在圣保罗圣卡塔琳娜医学院头颈外科进行的横断面临床试验。

方法

从32例患者收集甲状腺组织样本,分为两组:良性肿瘤组(A组)和恶性肿瘤组(B组)。提取DNA后,用聚合酶链反应扩增基因。

结果

B组中,两个基因的基因分型均为阳性的有4例,GSTT1阳性而GSTM1阴性的有7例,GSTT1阴性而GSTM1阳性的有2例,仅1例两个基因均为阴性。A组中,两个基因的基因分型均为阳性的有11例,无两个基因均为阴性的基因型。

结论

在本研究中,GSTT1和GSTM1基因的存在与甲状腺良性和恶性肿瘤之间无关联。

相似文献

1
Comparative analysis of the prevalence of the glutathione S-transferase (GST) system in malignant and benign thyroid tumor cells.恶性和良性甲状腺肿瘤细胞中谷胱甘肽S-转移酶(GST)系统患病率的比较分析。
Sao Paulo Med J. 2007 Sep 6;125(5):289-91. doi: 10.1590/s1516-31802007000500008.
2
Combined GSTM1 and GSTT1 null genotypes are associated with a lower risk of papillary thyroid cancer.谷胱甘肽S-转移酶M1(GSTM1)和谷胱甘肽S-转移酶T1(GSTT1)联合缺失基因型与乳头状甲状腺癌风险降低相关。
J Endocrinol Invest. 2008 Jun;31(6):542-5. doi: 10.1007/BF03346405.
3
The null genotype of glutathione s-transferase M1 and T1 locus increases the risk for thyroid cancer.
Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1485-8.
4
[GST genes expression as prognostic factor in papillary thyroid cancer].[谷胱甘肽S-转移酶基因表达作为甲状腺乳头状癌的预后因素]
Rev Assoc Med Bras (1992). 2009 May-Jun;55(3):279-82. doi: 10.1590/s0104-42302009000300019.
5
Molecular prognosticators and genomic instability in papillary thyroid cancer.
Laryngoscope. 2005 Aug;115(8):1479-85. doi: 10.1097/01.mlg.0000172045.38907.52.
6
Polymorphisms of methylenetetrahydrofolate reductase and glutathione S-transferase are not associated with the risk of papillary thyroid cancer in Korean population.亚甲基四氢叶酸还原酶和谷胱甘肽S-转移酶的多态性与韩国人群甲状腺乳头状癌的风险无关。
Mol Biol Rep. 2014 Jun;41(6):3793-9. doi: 10.1007/s11033-014-3245-z. Epub 2014 Feb 18.
7
Glutathione S-transferase GSTM1, GSTT1 and p53 codon 72 polymorphisms in human tumor cells.人肿瘤细胞中的谷胱甘肽S-转移酶GSTM1、GSTT1及p53密码子72多态性
Hum Cell. 2003 Dec;16(4):241-51. doi: 10.1111/j.1749-0774.2003.tb00158.x.
8
Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.谷胱甘肽 S-转移酶 (GSTM1、GSTT1、GSTP1) 基因多态性与膀胱癌易感性的关系。
Urol Oncol. 2013 Oct;31(7):1193-203. doi: 10.1016/j.urolonc.2011.11.027. Epub 2011 Dec 11.
9
Genetic Polymorphisms of Xenobiotic Metabolizing Genes (GSTM1, GSTT1, GSTP1), Gene-Gene Interaction with Association to Lung Cancer Risk in North India; A Case Control Study.印度北部外源性物质代谢基因(GSTM1、GSTT1、GSTP1)的基因多态性、基因-基因相互作用与肺癌风险的关联;一项病例对照研究
Asian Pac J Cancer Prev. 2019 Sep 1;20(9):2707-2714. doi: 10.31557/APJCP.2019.20.9.2707.
10
Glutathione S-transferase polymorphisms and risk of differentiated thyroid carcinomas: a case-control analysis.谷胱甘肽S-转移酶基因多态性与分化型甲状腺癌风险:一项病例对照分析。
Arch Otolaryngol Head Neck Surg. 2006 Jul;132(7):756-61. doi: 10.1001/archotol.132.7.756.

引用本文的文献

1
Functional polymorphisms in antioxidant genes in Hurthle cell thyroid neoplasm - an association of GPX1 polymorphism and recurrent Hurthle cell thyroid carcinoma.赫氏细胞甲状腺肿瘤中抗氧化基因的功能多态性——GPX1多态性与复发性赫氏细胞甲状腺癌的关联
Radiol Oncol. 2016 Jul 19;50(3):289-96. doi: 10.1515/raon-2016-0031. eCollection 2016 Sep 1.

本文引用的文献

1
Thyroid cancer: an overview.甲状腺癌:概述
Nucl Med Commun. 2004 Sep;25(9):861-7. doi: 10.1097/00006231-200409000-00001.
2
Glutathione S-transferase polymorphisms in thyroid cancer patients.甲状腺癌患者中的谷胱甘肽S-转移酶基因多态性
Cancer Lett. 2003 Feb 10;190(1):37-44. doi: 10.1016/s0304-3835(02)00580-3.
3
The null genotype of glutathione s-transferase M1 and T1 locus increases the risk for thyroid cancer.
Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1485-8.
4
Glutathione transferases with novel active sites isolated by phage display from a library of random mutants.
J Mol Biol. 1995 Jul 7;250(2):115-22. doi: 10.1006/jmbi.1995.0362.
5
Point mutations of ras oncogenes are an early event in thyroid tumorigenesis.
Mol Endocrinol. 1990 Oct;4(10):1474-9. doi: 10.1210/mend-4-10-1474.